Synthetic Studies toward Ecteinascidin 743
1H NMR (300 MHz CDCl3, 293 K) δ 6.13 (ddt, J ) 17.3, 10.8,
5.7 Hz, 1H), 6.06 (s, 1H), 6.03 (d, J ) 1.1 Hz, 1H), 5.95 (d, J
) 1.1 Hz, 1H), 5.44 (dq, J ) 17.6, 2.8 Hz, 1H), 5.28 (dq, J )
10.8, 1.5 Hz, 1H), 5.12 (d, J ) 3.1 Hz, 1H), 4.83 (d, J ) 12.1
Hz, 1H), 4.80 (d, J ) 12.1 Hz, 1H), 4.48 (ddt, J ) 13.2, 5.4, 0.9
Hz, 1H), 4.36 (dd, J ) 13.3, 3.8 Hz, 1H), 4.26 (ddt, J ) 13.2,
5.4, 1.9 Hz, 1H), 4.20 (q, J ) 7.1 Hz, 3H), 3.78 (m, 1H), 2.15
AcOEt and filtered. The combined filtrate was concentrated
in vacuo to furnish the crude oxazolidine 38a. To the solution
of the crude 38a in CH2Cl2 (2.4 mL), cooled to -30 °C, were
added TMSCN (93.0 mg, 126.0 µL, 0.94 mmol) and BF3.OEt2
(33.0 µL, 0.26 mmol), successively. After being stirred at -30
°C for 1.5 h, the reaction was quenched with saturated
NaHCO3 and extracted with AcOEt. The organic phase was
dried over Na2SO4 and concentrated under reduced pressure.
The resulting crude product was purified by flash column
chromatography to afford the aminonitrile 39a as two sepa-
rable diastereomers. The major isomer (96.0 mg, 0.14 mmol,
(s, 3H), 1.60 (s, 3H), 1.39 (s, 3H), 1.27 (t, J ) 7.1 Hz, 3H); 13
C
NMR (62.5 MHz CDCl3, 293 K) δ 171.1, 169.5, 151.3, 147.2,
140.0, 133.7, 118.1, 116.9, 114.2, 110.1, 101.6, 99.9, 95.1, 75.4,
74.9, 63.1, 62.0, 61.5, 55.3, 52.2, 27.7, 20.9, 14.1, 9.5; LRMS
(ESI+) m/z 602.0, 604.0 (M + Na)+; HRMS (ESI+) m/z calcd
for C24H28NO9NaCl3 (M + Na)+ 602.0727 and 604.0698, found
602.0728 and 604.0701.
23
60% for two steps): [R]D ) -24° (c 0.47 CHCl3); IR (CHCl3)
ν 3447, 3019, 2959, 2929, 2401, 1719, 1511, 1232 cm-1 1H
;
NMR (300 MHz CDCl3, 293 K) δ 6.68 (s, 1H), 6.66 (s, 1H),
6.11 (m, 2H), 6.06 (d, J ) 1.3 Hz, 1H), 5.98 (d, J ) 1.3 Hz,
1H), 5.90 (m, 1H), 5.47 (br.d, 1H), 5.41-5.23 (m, 6H), 5.02 (d,
J ) 7.9 Hz, 1H), 4.55 (m, 5H), 4.45 (m, 1H), 4.39 (ddt, J )
12.1, 5.1, 1.2 Hz, 1H), 4.31 (ddt, J ) 12.1, 4.9, 1.0 Hz, 1H),
4.12 (m, 2H), 3.95 (m, 1H), 3.85 (m, 5H), 3.32 (dd, J ) 13.9,
3.1 Hz, 1H), 3.11 (m, 1H), 2.97 (dd, J ) 13.5, 10.2 Hz, 1H),
2.54 (m, 1H), 2.24 (s, 3H), 2.16 (s, 3H), 1.60 (s, 3H), 1.40 (s,
3H); 13C NMR (75 MHz CDCl3, 293 K) δ 155.8, 151.5, 150.1,
147.1, 146.4, 139.7, 133.6, 133.4, 132.6, 132.5, 132.0, 123.8,
118.8, 117.7, 117.4, 117.1, 116.9, 114.0, 112.9, 112.6, 101.7,
99.3, 75.7, 69.3, 66.3, 65.8, 63.0, 62.5, 61.4, 60.1, 55.8, 55.4,
54.2, 35.8, 29.3, 19.2, 15.9, 9.3; HRMS (ESI+) m/z calcd for
C38H47N3O10Na (M + Na)+ 728.3159, found 728.3167. The
1,3-cis-Tetrahydroisoquinoline 24. To a solution of N-
Troc amine 22 (326.0 mg, 0.56 mmol) in dry THF (3.0 mL)
was added DBU (0.134 mL, 1.13 mmol) dropwise. After being
stirred at room temperature for 14 h, the reaction mixture was
diluted with water and extracted with Et2O. The combined
organic extracts were washed with brine, dried over Na2SO4,
and concentrated under reduced pressure. The crude product
was used directly for next step. To a solution of crude 1,3-cis-
N-Troc amine 23 in Et2O/AcOH (10:1, v/v, 6.0 mL) was added
Zn powder (2.7 g, 42.0 mmol). After being stirred at room
temperature for 1 h, the reaction mixture was diluted with
diethyl ether (100 mL) and filtered with a short pad of Celite.
The filtrate was washed with saturate aqueous NaHCO3,
brine, dried over Na2SO4, and concentrated under reduced
pressure. The residue was purified by flash column chroma-
tography to afford amine 24 (205.0 mg, 0.51 mmol, 90%) as a
colorless oil. [R]2D3 ) -2° (c 0.4, CHCl3); IR (CHCl3) ν 3018,
1738, 1458, 1382, 1223, 1103 cm-1; 1H NMR (300 MHz CDCl3,
293 K) δ 6.11 (ddt, J ) 16.9, 10.3, 5.5 Hz, 1H), 5.94 (d, J ) 1.2
Hz, 1H), 5.91 (d, J ) 1.2 Hz, 1H), 5.43 (dq, J ) 17.1, 2.8 Hz,
1H), 5.27 (dq, J ) 10.9, 1.3 Hz, 1H), 5.09 (d, J ) 1.0 Hz, 1H),
4.71 (s, 1H), 4.56 (ddt, J ) 12.5, 5.3, 1.7 Hz, 1H), 4.32-4.28
(m, 3H), 4.24 (m, 1H), 3.94 (dd, J ) 11.4, 1.1 Hz, 1H), 2.53 (m,
1H), 2.15 (s, 3H), 1.66 (s, 3H), 1.44 (s, 3H), 1.32 (t, J ) 7.1 Hz,
3H); 13C NMR (62.5 MHz CDCl3, 293 K) δ 171.2, 151.2, 146.4,
139.3, 133.9, 120.9, 116.3, 113.1, 112.8, 101.2, 98.8, 75.2, 64.6,
61.4, 60.1, 57.5, 49.3, 29.6, 18.7, 13.9, 9.1; HRMS (ESI+) m/z
calcd for C21H27NO7Na (M + Na)+ 428.1685, found 428.1714.
Amino Ester 32. To a solution of imine 30 (3.4 g, 11.2
mmol) and O(9)-allyl-N-(9-anthracenylmethyl) cinchonidinium
bromide 31 (0.6 g, 1.1 mmol) in CH2Cl2 (12 mL) were added
CsOH‚H2O (18.8 g, 111.7 mmol) and a CH2Cl2 (8 mL) solution
of bromide 29 (4.3 g, 11.2 mmol) dropwise at -78 °C. After
being stirred vigorously at -78 °C for 30 h, the suspension
was diluted with ether, washed with water, dried over Na2-
SO4, filtered and concentrated in vacuo. The residue was
dissolved in HOAc/THF/H2O (1:1:1, 57 mL) and the resulting
solution was stirred at room temperature for 2 h. The solution
was then made basic by addition of solid NaHCO3 and water.
The aqueous phase was extracted with AcOEt. The combined
organic extracts were washed with brine and dried over Na2-
SO4. After concentration and column chromatography, the
amino ester 32 (4.3 g, 87%) was isolated as a colorless oil.
[R]2D3 ) +13° (c 0.8, CHCl3); IR (CHCl3) ν 3382, 3034, 2981,
2938, 1725, 1598, 1495, 1370, 1293, 1218, 1178 cm-1; 1H NMR
(250 MHz CDCl3, 293 K) δ 7.78 (d, J ) 7.6 Hz, 2H), 7.32 (d, J
) 7.5 Hz, 2H), 6.90 (s, 1H), 6.79 (s, 1H), 3.67 (s, 3H), 3.51-
3.45 (dd, J ) 7.3, 5.5 Hz, 1H), 2.92-2.84 (dd, J ) 13.7, 5.5
Hz, 1H), 2.71-2.63 (dd, J ) 13.7, 7.7 Hz, 1H), 2.44 (s, 3H),
2.19 (s, 3H), 1.42 (s, 9H); 13C NMR (75 MHz CDCl3, 293 K) δ
174.0, 149.3, 145.1, 142.2, 133.2, 133.1, 132.8, 130.4, 129.5
(×2), 128.4 (×2), 121.8, 81.2, 60.5, 56.0, 40.2, 27.9 (×3), 21.6,
15.9; HRMS (ESI+) m/z calcd for C22H30NO6S + H (M + H)+
436.1795, found 436.1789.
23
minor isomer (36.0 mg, 0.05 mmol, 22% for two steps): [R]D
) -2° (c 0.51 CHCl3); IR (CHCl3) ν 3434, 3013, 2929, 2399,
1715, 1496, 1232 cm-1; H NMR (300 MHz CDCl3, 293 K) δ
1
6.64 (s, 1H), 6.63 (s, 1H), 6.11 (m, 2H), 6.02 (d, J ) 1.5 Hz,
1H), 6.00 (d, J ) 1.5 Hz, 1H), 5.90 (m, 1H), 5.63 (d, J ) 5.9
Hz, 1H), 5.46 (dd, J ) 16.9, 2.2 Hz, 2H), 5.33 (d, J ) 2.9 Hz,
1H), 5.35-5.20 (m, 4H), 4.58 (m, 4H), 4.39 (ddt, J ) 12.5, 5.1,
1.5 Hz, 2H), 4.31 (ddt, J ) 12.5, 5.9, 1.5 Hz, 1H), 4.07-4.01
(m, 2H), 3.87 (m, 1H), 3.85 (s, 3H), 3.70 (br.d, J ) 12.5 Hz,
1H), 3.58 (m, 1H), 3.17 (dd, J ) 14.0, 4.4 Hz, 1H), 3.10 (dd, J
) 14.0, 8.8 Hz, 1H), 2.51 (m, 1H), 2.26 (s, 3H), 2.16 (s, 3H),
1.56 (s, 3H), 1.41 (s, 3H); 13C NMR (75 MHz CDCl3, 293K) δ
156.0, 151.4, 150.1, 147.0, 146.6, 139.5, 133.6, 133.3, 132.6,
132.1, 131.9, 124.0, 118.9, 117.6, 117.4, 117.2, 117.1, 113.9,
113.0, 112.9, 101.6, 99.2, 75.7, 69.4, 65.9, 65.7, 62.9, 62.5, 60.1,
58.7, 55.8, 55.7, 54.6, 29.7, 29.1, 19.2, 15.9, 9.3; HRMS (ESI+)
m/z calcd for C38H47N3O10Na (M + Na)+ 728.3159, found
728.3132.
Aminonitrile 39b. In a manner similar to that used in the
preparation of 39a, treatment of 10b (824.0 mg, 2.02 mmol)
and 9 (490.0 mg, 1.35 mmol) gave 39b (590.0 mg, 0.75 mmol,
56% for the major isomer) as a colorless oil. [R]2D3 ) -29° (c
1.0 CHCl3); IR (CHCl3) ν 3447, 3016, 2930, 2229, 1719 (forte),
1585, 1490, 1384, 1200, 1113 cm-1; 1H NMR (300 MHz CDCl3,
293 K) δ 6.66 (s, 1H), 6.58 (s, 1H), 6.07 (m, 1H), 5.99 (d, J )
1.2 Hz, 1H), 5.95 (d, J ) 1.2 Hz, 1H), 5.85 (m, 1H), 5.17-5.45
(m, 4H), 5.37 (d, J ) 2.6 Hz, 1H), 5.03 (d, J ) 6.8 Hz, 1H),
4.54 (m, 2H), 4.43 (m, 1H), 4.39 (m, 1H), 4.25 (ddt, J ) 12.1,
5.1, 1.0 Hz, 1H), 3.96-4.16 (m, 3H), 3.73-3.92 (m, 3H), 3.73
(s, 3H), 3.29 (dd, J ) 13.6, 3.1 Hz, 1H), 3.11 (m, 1H), 2.93 (dd,
J ) 13.5, 10.2 Hz, 1H), 2.51 (br.s, 1H), 2.22 (s, 3H), 2.14 (s,
3H), 1.58 (s, 3H), 1.42 (s, 3H), 0.97 (s, 9H), 0.16 (s, 6H); 13C
NMR (75 MHz CDCl3, 293 K) δ 156.5, 150.9, 149.5, 149.3,
147.9, 140.5, 134.5, 134.4, 133.4, 133.2, 125.2, 120.7, 119.6,
118.6, 118.0, 117.7, 114.8, 113.7, 102.5, 100.1, 76.6, 67.1, 66.6,
63.8, 63.4, 62.1, 60.6, 56.7, 56.3, 55.1, 36.2, 30.1, 26.5 (×3),
20.0, 19.1, 16.8, 10.1, -4.2 (×2); LRMS (ESI+) m/z 802.4 (M +
Na)+; HRMS (ESI+) m/z calcd for C41H57N3O10SiNa (M + Na)+
802.3711, found 802.3704.
Macrolactone 44a. To a solution of the ester 43a (55.0 mg,
0.42 mmol) in TFE (5.0 mL) at 0 °C was added a solution of
TFA (60.0 µL) in TFE (1.0 mL) and the resulting mixture was
stirred at room temperature for 2 h. The reaction mixture was
quenched with saturated NaHCO3 and extracted with EtOAc.
The organic phase was dried over Na2SO4 and concentrated
Aminonitrile 39a. To a solution of amino alcohol 9 (85 mg,
0.23 mmol) and aldehyde 10a (117.0 mg, 0.35 mmol) in toluene
(1.2 mL) was added 3 Å molecular sieves (260.0 mg). After
being stirred at 40 °C overnight, the mixture was diluted with
J. Org. Chem, Vol. 70, No. 11, 2005 4407